Glycilarc Trio 2/0.3mg Tablet ER
By Glycilarc Trio
Rx
10 Tablet ER in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Wynclark Pharmaceuticals Private Limited
Ground Floor,12-7-20/64/2, Survey No. 793, Goods Shed Road, Moosapet, Kukatpally, Hyderabad TG 500018 India

Expires on or after
July, 2026

liver
When using Glycilarc Trio 2/0.3mg Tablet ER, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Glycilarc Trio 2/0.3mg Tablet ER. It is advised to consult your doctor before starting this medication. Particularly in cases of mild to moderate liver disease, Glycilarc Trio 2/0.3mg Tablet ER is usually initiated at a low dose. However, it is not recommended for use in patients with severe liver disease.

kidney
Glycilarc Trio 2/0.3mg Tablet ER should be avoided in patients with kidney disease. It is not recommended for those with severe kidney disease. Consulting your doctor is advised before using this medication.

alcohol
It is not safe to consume alcohol with Glycilarc Trio 2/0.3mg Tablet ER. Make sure to avoid alcohol while taking this medication.

driving
Driving while taking Glycilarc Trio 2/0.3mg Tablet ER may be unsafe if you experience low or high blood sugar levels. Avoid driving if you notice these symptoms.

pregnancy
Glycilarc Trio 2/0.3mg Tablet ER may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a careful evaluation before considering this medication.

breastfeeding
Glycilarc Trio 2/0.3mg Tablet ER should be avoided during breastfeeding as it may pass into the breastmilk and potentially harm the baby. It is advised to consult a doctor before using this medication while breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹165.5
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024
